Common clinical indications

• Combination antiretroviral therapy for HIV-1 infection in adults and children (see current HIV treatment guidelines for full dosing and regimen recommendations).
• Presumptive HIV therapy in high-risk vertical transmission scenarios in term neonates (in combination with zidovudine and lamivudine).

Frequently asked questions

What is Raltegravir used for?

Raltegravir (Raltegravir) is listed in YMed Atlas under Antiretroviral agent, integrase inhibitor. Indications, dosing, and safety information on this page summarize curated references—always confirm with current labeling, formularies, and local protocols.

How do I adjust dosing for renal impairment or special populations?

Review the dosing sections and references for this monograph. Many agents require renal or hepatic adjustment; pediatric, pregnancy, and lactation considerations are clinician-specific. This interface is educational and does not replace individualized prescribing decisions.

Is this medical advice?

No. YMed Atlas drug pages support learning and quick reference. They are not a substitute for clinical judgment, pharmacist review, or formal interaction checking with a complete medication list.